With the help of the data and tweets given, can you forecast whether the closing price of $bmy will climb or drop at 2017-03-10? Please state either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-24,-0.9,0.1,-1.0,1.2,1.2,-1.9,-3.7,-5.4,-7.3,-8.5,-7.2
2017-02-27,-0.1,0.8,-0.6,0.2,0.2,-1.4,-3.0,-5.0,-6.8,-8.2,-7.4
2017-02-28,-0.3,0.4,-0.9,0.3,0.3,-1.0,-2.4,-4.5,-6.3,-8.0,-7.6
2017-03-01,-0.3,0.1,-1.2,0.8,0.8,-1.1,-2.6,-4.7,-6.4,-8.2,-8.3
2017-03-02,0.1,1.1,-0.5,-0.6,-0.6,-0.2,-1.8,-3.6,-5.2,-7.1,-7.8
2017-03-03,-0.9,0.1,-1.1,0.7,0.7,-0.6,-1.9,-3.6,-5.2,-7.1,-8.3
2017-03-06,0.1,0.5,-1.3,-0.5,-0.5,0.0,-1.0,-2.5,-4.2,-5.9,-7.4
2017-03-07,-0.1,0.5,-1.0,-1.1,-1.1,1.0,0.4,-0.8,-2.7,-4.3,-6.0
2017-03-08,-1.4,0.7,-1.6,1.4,1.4,-0.4,-0.7,-1.8,-3.5,-5.1,-6.8
2017-03-09,-1.1,0.1,-1.4,1.5,1.5,-1.5,-1.8,-2.9,-4.5,-5.9,-7.7

2017-02-24: rt AT_USER clovis oncology, inc. $clvs gets news from fda, merrill lynch  $ibb $xbi $atra exel $tsro $celg $bmy¡­|clovis oncology, inc. $clvs gets news from fda, merrill lynch  $ibb $xbi $atra exel $t
2017-02-25: benzinga: carl icahn's track record in big pharma  $bmy $lly $biib $sny $agn $azn|carl icahn's track record in big pharma  $bmy $lly $biib $sny $agn $azn|rt AT_USER pharmalot.. pharmalittle.. good mor
2017-02-27: rt AT_USER biotech partnering is a many-splendored thing  $exel $bmy #cancer |biotech partnering is a many-splendored thing  $exel $bmy #cancer |biotech partnering is a many-splendored thing  $exel $b
2017-03-01: rt AT_USER AT_USER $nwbo p3 trial could be halted by AT_USER any day due to overwhelming efficacy as $bmy #opdivo has #checkmat¡­|$bmy bristol-myers squibb to present data that advances understanding 
2017-03-02: 5 things for #pharma #marketers to know: thurs., mar. 2 $pfe $jnj $mrk $bmy $lly #drugpricing #patients $nvo¡­ |rt AT_USER why did infinity pharmaceuticals, inc. $infi gain +20%?  $bmy #cancer #biotec
2017-03-03: why short sellers are making a massive bet in major pharma  $pfe $mrk $teva $bmy $abbv $lly |why short sellers are making a massive bet in major pharma  $pfe $mrk $teva $bmy $abbv $lly |$bmy is in bul
2017-03-04: rt AT_USER new features coming soon! free week demo:  #ascendtrader $spy $qqq $arwr $bmy $pot $snap $aapl $t¡­|rt AT_USER new AT_USER blank space use? $twtr $hlf $iep $myl $bmy $agn $spy $spx AT_USER 
2017-03-05: this writer is a liar! they did not say that! $agn myl $mrk $jnj $amgn $bmy $teva $ipxl $fb $prgo $nvs $sny $lly |insider buying steady as market again hits all-time highs  $arnc $jmba $musa $bmy $sm 
2017-03-06: bristol-myers squibb and innate pharma: innovation is never a single event  $azn $bmy $mrk $nvo $sny $iphyf|salphatrending: bristol-myers squibb (bmy) ceo giovanni caforio presents at cowen and compan
2017-03-07: bristol-myers squibb co $bmy evp sells $5,268,933.10 in stock |traders buy bristol-myers squibb co $bmy on weakness following insider selling |bristol-myers squibb co $bmy evp sells $5,268,933.10 in s
2017-03-08: $bmy looks good right now even if it's not a buyout target #stocks |rt AT_USER AT_USER #goboldly #cure $nwbo $bmy cure AT_USER p3 topline data tba |rt AT_USER AT_USER #goboldly #cure $nwbo $bmy cure A
2017-03-09: why short sellers are making a massive bet in major pharma  $pfe $mrk $teva $bmy $abbv $lly |AT_USER AT_USER read the structure of the $bmy trial in that article, its very clear about endpt definition
Answer:
date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-24,-0.9,0.1,-1.0,1.2,1.2,-1.9,-3.7,-5.4,-7.3,-8.5,-7.2
2017-02-27,-0.1,0.8,-0.6,0.2,0.2,-1.4,-3.0,-5.0,-6.8,-8.2,-7.4
2017-02-28,-0.3,0.4,-0.9,0.3,0.3,-1.0,-2.4,-4.5,-6.3,-8.0,-7.6
2017-03-01,-0.3,0.1,-1.2,0.8,0.8,-1.1,-2.6,-4.7,-6.4,-8.2,-8.3
2017-03-02,0.1,1.1,-0.5,-0.6,-0.6,-0.2,-1.8,-3.6,-5.2,-7.1,-7.8
2017-03-03,-0.9,0.1,-1.1,0.7,0.7,-0.6,-1.9,-3.6,-5.2,-7.1,-8.3
2017-03-06,0.1,0.5,-1.3,-0.5,-0.5,0.0,-1.0,-2.5,-4.2,-5.9,-7.4
2017-03-07,-0.1,0.5,-1.0,-1.1,-1.1,1.0,0.4,-0.8,-2.7,-4.3,-6.0
2017-03-08,-1.4,0.7,-1.6,1.4,1.4,-0.4,-0.7,-1.8,-3.5,-5.1,-6.8
2017-03-09,-1.1,0.1,-1.4,1.5,1.5,-1.5,-1.8,-2.9,-4.5,-5.9,-7.7

2017-02-24: rt AT_USER clovis oncology, inc. $clvs gets news from fda, merrill lynch  $ibb $xbi $atra exel $tsro $celg $bmy¡­|clovis oncology, inc. $clvs gets news from fda, merrill lynch  $ibb $xbi $atra exel $t
2017-02-25: benzinga: carl icahn's track record in big pharma  $bmy $lly $biib $sny $agn $azn|carl icahn's track record in big pharma  $bmy $lly $biib $sny $agn $azn|rt AT_USER pharmalot.. pharmalittle.. good mor
2017-02-27: rt AT_USER biotech partnering is a many-splendored thing  $exel $bmy #cancer |biotech partnering is a many-splendored thing  $exel $bmy #cancer |biotech partnering is a many-splendored thing  $exel $b
2017-03-01: rt AT_USER AT_USER $nwbo p3 trial could be halted by AT_USER any day due to overwhelming efficacy as $bmy #opdivo has #checkmat¡­|$bmy bristol-myers squibb to present data that advances understanding 
2017-03-02: 5 things for #pharma #marketers to know: thurs., mar. 2 $pfe $jnj $mrk $bmy $lly #drugpricing #patients $nvo¡­ |rt AT_USER why did infinity pharmaceuticals, inc. $infi gain +20%?  $bmy #cancer #biotec
2017-03-03: why short sellers are making a massive bet in major pharma  $pfe $mrk $teva $bmy $abbv $lly |why short sellers are making a massive bet in major pharma  $pfe $mrk $teva $bmy $abbv $lly |$bmy is in bul
2017-03-04: rt AT_USER new features coming soon! free week demo:  #ascendtrader $spy $qqq $arwr $bmy $pot $snap $aapl $t¡­|rt AT_USER new AT_USER blank space use? $twtr $hlf $iep $myl $bmy $agn $spy $spx AT_USER 
2017-03-05: this writer is a liar! they did not say that! $agn myl $mrk $jnj $amgn $bmy $teva $ipxl $fb $prgo $nvs $sny $lly |insider buying steady as market again hits all-time highs  $arnc $jmba $musa $bmy $sm 
2017-03-06: bristol-myers squibb and innate pharma: innovation is never a single event  $azn $bmy $mrk $nvo $sny $iphyf|salphatrending: bristol-myers squibb (bmy) ceo giovanni caforio presents at cowen and compan
2017-03-07: bristol-myers squibb co $bmy evp sells $5,268,933.10 in stock |traders buy bristol-myers squibb co $bmy on weakness following insider selling |bristol-myers squibb co $bmy evp sells $5,268,933.10 in s
2017-03-08: $bmy looks good right now even if it's not a buyout target #stocks |rt AT_USER AT_USER #goboldly #cure $nwbo $bmy cure AT_USER p3 topline data tba |rt AT_USER AT_USER #goboldly #cure $nwbo $bmy cure A
2017-03-09: why short sellers are making a massive bet in major pharma  $pfe $mrk $teva $bmy $abbv $lly |AT_USER AT_USER read the structure of the $bmy trial in that article, its very clear about endpt definition